paclitaxel has been researched along with Cirrhosis in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.25) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 18 (56.25) | 24.3611 |
| 2020's | 6 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Duan, H; Gao, Z; Hou, Y; Huang, W; Jin, M; Liu, C; Liu, W; Liu, Y; Xin, X; Zhang, X; Zhang, Z; Zhao, H | 1 |
| Chen, J; Jiang, H; Xia, Y; Xu, F; Zhang, D; Zhang, G | 1 |
| Chen, S; Chen, ZW; Hu, JF; Huang, L; Huang, Y; Kang, FP; Li, G; Liao, CY; Lin, CF; Lin, HY; Tian, YF; Wang, ZW; Wu, YD; Xie, CK; Zhu, SC | 1 |
| Chen, X; He, Q; Li, M; Liu, Y; Sheng, Q; Shi, K; Wang, Y; Yu, Q; Zhang, Z | 1 |
| Adir, O; Alyan, M; Binenbaum, Y; Dvir, T; Fridman, E; Gibori, H; Gil, Z; Hershkovitz, D; Kasten, S; Koren, L; Krayem, M; Krinsky, N; Liba, L; Lübtow, MM; Luxenhofer, R; Milman, N; Mumblat, Y; Noor, N; Ofir, S; Poley, M; Satchi-Fainaro, R; Schroeder, A; Shainsky-Roitman, J; Shklover, J; Simon, A; Yaari, Z; Zinger, A | 1 |
| Kang, JS; Lee, EY; Son, SS | 1 |
| Amoroso, A; Calvo, PL; Catalano, S; Chiadò, C; Chiusa, L; David, E; Deaglio, S; Dell'Olio, D; Isolato, G; Pinon, M; Pizzol, A; Romagnoli, R; Tandoi, F | 1 |
| Annan, DA; Cong, L; Hida, K; Hida, Y; Maishi, N; Morimoto, H; Morimoto, M; Nam, JM; Young, MF | 1 |
| Benoit, JP; Contini, A; Hureaux, J; Lacoeuille, F; Lagarce, F; Rousselet, MC; Saulnier, P; Urban, T | 1 |
| Grabow, N; Guthoff, RF; Reske, T; Schmidt, W; Schmitz, KP; Siewert, S; Stahnke, T; Wree, A | 1 |
| Chen, X; Chen, Y; Ding, J; Luan, J; Shen, W; Sun, J; Yang, X; Yu, L; Zhang, Z | 1 |
| Chen, L; Gao, Z; Huang, W; Jin, M; Jin, Z; Wang, M; Wang, Q | 1 |
| Fujimura, T; Fushida, S; Harada, S; Kinoshita, J; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Terai, S; Tsukada, T; Yagi, Y | 1 |
| Adden, N; Braune, M; Riedmüller, J; Savard, C; Waksman, R; Wittchow, E | 1 |
| Afari, ME; Buszman, PP; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Peppas, A; Rousselle, SD; Stenoien, M; Tellez, A | 1 |
| Chen, J; Dong, Z; He, Z; Wang, S; Xiang, X; Xu, X; Yang, J; Yang, R; Zhang, D; Zhang, L; Zhao, Y | 1 |
| Giles, RH; Lilien, MR; Slaats, GG | 1 |
| Han, JS; Heo, NJ; Joo, KW; Jung, ES; Kim, DK; Kim, S; Lee, J | 1 |
| Althoff, CE; Günther, RW; Hamm, B; Langmann, M; Marticorena Garcia, SR; Schnorr, B | 1 |
| Han, SJ; Kim, JH; Kim, JI; Park, KM | 1 |
| Bergler-Klein, J; Gray, WA; Gyöngyösi, M; Jambrik, Z; Lukovic, D; Maurer, G; Pavo, IJ; Pavo, N; Plass, CA; Sabdyusheva, I; Samaha, E; Stahnke, S; von Strandmann, RP; Zlabinger, K | 1 |
| Kolodgie, FD; Ladich, E; Mori, H; Pacheco, E; Virmani, R; Yahagi, K | 1 |
| Albert, PS; Citrin, D; Colevas, AD; Cooley-Zgela, T; Cotrim, A; Herscher, L; Likhacheva, A; Mansueti, J; Morris, JC; Rudy, SF; Russo, A; Sciuto, L; Smith, S; Solomon, B; Van Waes, C | 1 |
| Baim, DS; Herbst, TJ; Huibregtse, B; Nakazawa, G; Poff, B; Schwartz, RS; Virmani, R; Wilson, GJ | 1 |
| Kanwar, YS; Kondeti, VK; Ling, G; Liu, F; Liu, Y; Sun, L; Xiang, X; Xiao, L; Yang, Y; Zhan, M; Zhang, D; Zhu, X | 1 |
| Guthoff, R; Kastner, C; Löbler, M; Schmitz, KP; Stachs, O; Stahnke, T; Sternberg, K; Wree, A | 1 |
| Dong, C; Goldschmidt-Clermont, PJ; Hummers, L; Liu, X; Wang, T; Wigley, FM; Zhu, S | 1 |
| Choi, HS; Choi, JW; Kuver, R; Lee, SP; Savard, CE | 1 |
| Jampel, HD; Leong, KW; Quigley, HA; Thibault, D; Uppal, P | 1 |
| Eisele, DW; Forastiere, AA; Lee, DJ; Westra, WH | 1 |
| Ajaikumar, BS; Cleveland, MG; Reganti, R | 1 |
| Ahmadi, MA; Booser, D; Esmaeli, B; Valero, V | 1 |
1 review(s) available for paclitaxel and Cirrhosis
| Article | Year |
|---|---|
Nephronophthisis: should we target cysts or fibrosis?
Topics: Animals; Ciliopathies; Fibrosis; Humans; Kidney; Kidney Diseases, Cystic; Kidney Failure, Chronic; Microtubules; Paclitaxel; Risk Factors; Signal Transduction; Treatment Outcome; Urological Agents | 2016 |
1 trial(s) available for paclitaxel and Cirrhosis
| Article | Year |
|---|---|
Squamous cell granulomas of the neck: histologic regression of metastatic squamous cell carcinoma following chemotherapy and/or radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Culture Techniques; Diagnosis, Differential; Female; Fibrosis; Fluorouracil; Granuloma, Foreign-Body; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Registries; Remission Induction; Tirapazamine; Triazines | 1998 |
30 other study(ies) available for paclitaxel and Cirrhosis
| Article | Year |
|---|---|
Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System.
Topics: Cell Line, Tumor; Drug Delivery Systems; Fibrosis; Humans; Liposomes; Micelles; Paclitaxel; Quercetin; Tumor Microenvironment | 2022 |
Low dose Taxol ameliorated renal fibrosis in mice with diabetic kidney disease by downregulation of HIPK2.
Topics: Animals; Collagen; Diabetes Mellitus; Diabetic Nephropathies; Down-Regulation; Fibrosis; Kidney; Mice; Paclitaxel; Protein Serine-Threonine Kinases; Signal Transduction; Tumor Suppressor Protein p53 | 2023 |
A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM-STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Fibrosis; Humans; Paclitaxel; RNA-Binding Proteins; RNA, Small Interfering; Stathmin; Transforming Growth Factor beta1; Tumor Microenvironment | 2023 |
Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
Topics: Animals; Antineoplastic Agents; Autophagy; Cancer-Associated Fibroblasts; Carcinoma, Pancreatic Ductal; Disease Progression; Female; Fibrosis; Humans; Hydroxychloroquine; Irinotecan; Liposomes; Mice; Mice, Nude; Nanomedicine; Neoplasm Metastasis; Neoplasm Transplantation; NIH 3T3 Cells; Paclitaxel; Pancreatic Neoplasms; Peptides; Wound Healing | 2019 |
Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Membrane Permeability; Collagen; Collagenases; Disease Models, Animal; Extracellular Matrix; Fibrosis; Humans; Liposomes; Mice; Nanoparticles; Paclitaxel; Pancreas; Tumor Microenvironment | 2019 |
Paclitaxel Ameliorates Palmitate-Induced Injury in Mouse Podocytes.
Topics: Animals; Antioxidants; Apoptosis; Cell Death; Cell Line; Cell Survival; Endoplasmic Reticulum Stress; Fibrosis; Inflammation; Mice; Paclitaxel; Palmitates; Podocytes; Reactive Oxygen Species | 2020 |
Evaluation of Graft Fibrosis, Inflammation, and Donor-specific Antibodies at Protocol Liver Biopsies in Pediatric Liver Transplant Patients: A Single-center Experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Cross-Sectional Studies; Doxorubicin; Fibrosis; Graft Rejection; Graft Survival; HLA Antigens; Humans; Inflammation; Isoantibodies; Liver; Liver Transplantation; Paclitaxel; Retrospective Studies | 2022 |
Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy.
Topics: Angiopoietin-2; Animals; Biglycan; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Fibrosis; Humans; Mice; Mice, Knockout; Neoplasm Metastasis; Neovascularization, Pathologic; Paclitaxel; Prognosis; Signal Transduction; Stromal Cells; Treatment Outcome; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2021 |
Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Topics: Aerosols; Animals; Biological Products; Cell Line; Drug Carriers; Drug Delivery Systems; Female; Fibrosis; Humans; Lipids; Lung; Nanocapsules; Paclitaxel; Phospholipids; Pulmonary Alveoli; Rats, Sprague-Dawley; Surface Tension; Tissue Distribution | 2017 |
Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents.
Topics: Animals; Caffeic Acids; Drug Delivery Systems; Drug-Eluting Stents; Fibrosis; Glaucoma; Male; Paclitaxel; Phenylethyl Alcohol; Pyridones; Rats; Rats, Wistar | 2018 |
Thermogel Loaded with Low-Dose Paclitaxel as a Facile Coating to Alleviate Periprosthetic Fibrous Capsule Formation.
Topics: Animals; Coated Materials, Biocompatible; Fibrosis; Foreign-Body Reaction; Gels; Micelles; Paclitaxel; Prostheses and Implants; Rats | 2018 |
Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes.
Topics: Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Cholesterol; Collagen Type I; Cytokines; Endocytosis; Female; Fibroblasts; Fibrosis; Fluorescence; Humans; Keloid; Liposomes; Male; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Wound Healing | 2019 |
Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.
Topics: Actins; Antigens, CD; Antineoplastic Agents, Phytogenic; Cadherins; Cell Line, Tumor; Cell Shape; Cisplatin; Collagen Type I; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Fibrosis; Fluorouracil; Gene Expression; Humans; Paclitaxel; Phosphorylation; Protein Processing, Post-Translational; Smad2 Protein; Stomach Neoplasms; Transforming Growth Factor beta | 2013 |
Bioresorbable drug-eluting magnesium-alloy scaffold: design and feasibility in a porcine coronary model.
Topics: Absorbable Implants; Alloys; Animals; Cardiovascular Agents; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Feasibility Studies; Female; Fibrosis; Kinetics; Magnesium; Male; Materials Testing; Models, Animal; Molecular Weight; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Polyglactin 910; Prosthesis Design; Swine; Swine, Miniature | 2013 |
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Constriction, Pathologic; Contrast Media; Disease Models, Animal; Equipment Design; Femoral Artery; Fibrosis; Hyperlipoproteinemia Type II; Iliac Artery; Iohexol; Neointima; Paclitaxel; Radiography; Sus scrofa; Tissue Distribution; Vascular Access Devices; Wound Healing | 2013 |
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Kidney; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Paclitaxel; STAT3 Transcription Factor; Tubulin | 2015 |
Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Male; Mitogen-Activated Protein Kinases; Paclitaxel; Plasminogen Activator Inhibitor 1; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Time Factors; Transforming Growth Factor beta1; Tubulin Modulators; Ureteral Obstruction | 2016 |
Use of Paclitaxel-Coated Balloon Catheter Dilation to Reduce In-Stent Restenosis in Transjugular Intrahepatic Portosystemic Shunt (TIPS).
Topics: Aged; Angioplasty, Balloon; Combined Modality Therapy; Drug-Eluting Stents; Female; Fibrosis; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Portasystemic Shunt, Transjugular Intrahepatic; Treatment Outcome; Tubulin Modulators | 2016 |
Inhibition of microtubule dynamics impedes repair of kidney ischemia/reperfusion injury and increases fibrosis.
Topics: Acetylation; Animals; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Colchicine; Disease Progression; Epithelial Cells; Fibrosis; Kidney; Macrophages; Male; Mice; Microtubules; Monocytes; Paclitaxel; Phosphorylation; RAW 264.7 Cells; Reperfusion Injury; Tubulin; Wound Healing | 2016 |
Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.
Topics: Angiography; Angioplasty, Balloon; Animals; Coated Materials, Biocompatible; Equipment Design; Femoral Artery; Fibrosis; Hyperplasia; Iliac Artery; Materials Testing; Models, Animal; Neointima; Paclitaxel; Sus scrofa; Swine; Tomography, Optical Coherence; Tunica Intima; Tunica Media; Vasoconstriction; Vasodilation | 2016 |
Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
Topics: Angioplasty, Balloon; Animals; Arterioles; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Vessels; Embolism; Equipment Design; Femoral Artery; Fibrosis; Models, Animal; Muscle, Skeletal; Necrosis; Neointima; Paclitaxel; Sus scrofa; Time Factors; Vascular Access Devices | 2016 |
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Feasibility Studies; Female; Fibrosis; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Skin; Survival Rate; Treatment Outcome | 2009 |
Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
Topics: Animals; Arteritis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Eosinophils; Female; Fibrin; Fibrosis; Granuloma, Foreign-Body; Paclitaxel; Sirolimus; Swine; Tunica Intima | 2009 |
Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192.
Topics: Animals; Cells, Cultured; Creatinine; Disease Models, Animal; Down-Regulation; Drug Administration Schedule; Drug Evaluation, Preclinical; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Hypertension, Renal; Kidney; Male; MicroRNAs; Nephrectomy; Paclitaxel; Proteinuria; Rats; Rats, Wistar; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Tubulin Modulators | 2011 |
Different fibroblast subpopulations of the eye: a therapeutic target to prevent postoperative fibrosis in glaucoma therapy.
Topics: Adipose Tissue; Cell Culture Techniques; Cell Proliferation; Choroid; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Fluorescent Antibody Technique, Indirect; Glaucoma; Glaucoma Drainage Implants; Humans; Immunoblotting; Mitomycin; Paclitaxel; Sclera; Tenon Capsule; Trabecular Meshwork; Trabeculectomy; Transforming Growth Factor beta1 | 2012 |
Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.
Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Biopsy; Dose-Response Relationship, Drug; Female; Fibrosis; Humans; Male; Mice; Mice, SCID; Middle Aged; Neovascularization, Pathologic; Paclitaxel; Phenotype; Scleroderma, Systemic; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Transplantation, Heterologous | 2005 |
Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts.
Topics: Animals; Cell Communication; Cell Proliferation; Cells, Cultured; Collagen Type I; Epithelial Cells; Fibroblasts; Fibrosis; Gallbladder; L-Lactate Dehydrogenase; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Paclitaxel; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2007 |
Glaucoma filtration surgery in nonhuman primates using taxol and etoposide in polyanhydride carriers.
Topics: Animals; Anterior Eye Segment; Drug Carriers; Drug Delivery Systems; Etoposide; Fibrosis; Glaucoma; Intraocular Pressure; Laser Therapy; Macaca fascicularis; Male; Paclitaxel; Polymers; Sclera; Sclerostomy | 1993 |
Cutaneous fibrosis induced by docetaxel: a case report.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Eruptions; Female; Fibrosis; Humans; Paclitaxel; Skin; Taxoids | 2000 |
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
Topics: Adult; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fibrosis; Humans; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids; Tears | 2001 |